Drug Pricing Trends, 340-B Regulations Among Sessions and Panel Discussions at Inaugural Event
(Chicago, IL) – Pricing professionals now have the opportunity to network and share ideas on the pharmaceutical pricing industry’s top concerns at the first-ever Pharmaceutical Pricing and Contracting Conference in Philadelphia, Pennsylvania, September 22-23, 2014. The conference, hosted by Q1 Productions, offers dozens of in-depth sessions, panel discussions and case studies led by pricing executives from small and large pharmaceutical companies.
Participants will have the opportunity to hear from some of the pharmaceutical industry’s most successful companies and meet with fellow pricing professionals during small group discussions focusing on the biggest challenges affecting pharmaceutical pricing and contracting teams. More than a dozen distinguished presenters will be on hand, including Manuel Duenas of Gilead Sciences, Craig Gibson of Celgene, Don Sawyer of Ironwood Pharmaceuticals, and Crystal Kuntz of America’s Health Insurance Plans.
With a variety of key regulatory changes this year as a result of the Affordable Care Act, topics addressing the new legislation on the Average Manufacturer’s Price and guidelines on 340-B eligibility will be among the main focuses at the two-day event. Other major evolutions in the market, such as the greater focus on rare disease treatments, will be addressed, putting meeting attendees on the forefront of this ever-changing sector.
For more information or to register for the Pharmaceutical Pricing and Contracting Conference, please visit www.q1productions.com or contact marketing@q1productions.com. You can also follow us on Twitter at @Q1Productions.
